{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:51:18Z","timestamp":1787165478408,"version":"build-2736575974"},"reference-count":92,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advanced Drug Delivery Reviews"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.addr.2018.04.003","type":"journal-article","created":{"date-parts":[[2018,4,5]],"date-time":"2018-04-05T19:48:12Z","timestamp":1522957692000},"page":"45-56","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"special_numbering":"C","title":["Repurposing excipients as active inhalation agents: The mannitol story"],"prefix":"10.1016","volume":"133","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6308-8770","authenticated-orcid":false,"given":"Sandra D.","family":"Anderson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangelia","family":"Daviskas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D.","family":"Brannan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hak Kim","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.addr.2018.04.003_bb0005","first-page":"459","article-title":"Sensitivity to heat and water loss at rest and during exercise in asthmatic patients","volume":"63","author":"Anderson","year":"1982","journal-title":"Eur. J. Respir. Dis."},{"key":"10.1016\/j.addr.2018.04.003_bb0010","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1172\/JCI108954","article-title":"Influence of heat and humidity on the airway obstruction induced by exercise in asthma","volume":"61","author":"Strauss","year":"1978","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.addr.2018.04.003_bb0015","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/0091-6749(84)90301-4","article-title":"Is there a unifying hypothesis for exercise-induced asthma?","volume":"73","author":"Anderson","year":"1984","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.addr.2018.04.003_bb0020","doi-asserted-by":"crossref","first-page":"215","DOI":"10.2500\/108854189778960054","article-title":"Exercise-induced asthma: a difference in opinion regarding the stimulus","volume":"10","author":"Anderson","year":"1989","journal-title":"Allergy Proc."},{"key":"10.1016\/j.addr.2018.04.003_bb0025","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/0091-6749(89)90309-6","article-title":"Inhalation provocation tests using non-isotonic aerosols","volume":"84","author":"Smith","year":"1989","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.addr.2018.04.003_bb0030","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1183\/09031936.93.03020144","article-title":"Inhalational challenge using hypertonic saline in asthmatic subjects: a comparison with responses to hyperpnoea, methacholine and water","volume":"3","author":"Smith","year":"1990","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.addr.2018.04.003_bb0035","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/0091-6749(86)90419-7","article-title":"Hyperosmolarity as the stimulus to asthma induced by hyperventilation?","volume":"77","author":"Smith","year":"1986","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.addr.2018.04.003_bb0040","series-title":"Asthma: Basic Mechanisms and Clinical Management","first-page":"473","article-title":"Asthma provoked by exercise, hyperventilation, and the inhalation of non-isotonic aerosols","author":"Anderson","year":"1992"},{"key":"10.1016\/j.addr.2018.04.003_bb0045","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1183\/09041950.053s1693","article-title":"Airway responsiveness: standardized challenge testing with pharmacological, physical and sensitizing stimuli in adults","volume":"6","author":"Sterk","year":"1993","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.addr.2018.04.003_bb0050","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1183\/09031936.93.04091126","article-title":"Inhaled clemastine inhibits airway narrowing caused by aerosols of non-isotonic saline","volume":"4","author":"Rodwell","year":"1991","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.addr.2018.04.003_bb0055","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1183\/09031936.93.05080953","article-title":"Inhaled steroids modify bronchial responses to hyperosmolar saline","volume":"5","author":"Rodwell","year":"1992","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.addr.2018.04.003_bb0060","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1164\/ajrccm\/146.5_Pt_1.1149","article-title":"Nedocromil sodium inhibits the airway response to hyperosmolar challenge in patients with asthma","volume":"146","author":"Rodwell","year":"1992","journal-title":"Am. Rev. Respir. Dis."},{"key":"10.1016\/j.addr.2018.04.003_bb0065","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1378\/chest.105.3.673","article-title":"Acute effect of sodium Cromoglycate on airway narrowing induced by 4.5-percent saline aerosol - outcome before and during treatment with aerosol corticosteroids in patients with asthma","volume":"105","author":"Anderson","year":"1994","journal-title":"Chest"},{"key":"10.1016\/j.addr.2018.04.003_bb0070","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2500\/108854197778612817","article-title":"Airway responsiveness in asthma: bronchial challenge with histamine and 4.5% sodium chloride before and after budesonide","volume":"18","author":"du Toit","year":"1997","journal-title":"Allergy Asthma Proc."},{"key":"10.1016\/j.addr.2018.04.003_bb0075","first-page":"233","article-title":"Lung function and bronchial provocation tests for intending divers with a history of asthma","volume":"25","author":"Anderson","year":"1995","journal-title":"SPUMS J."},{"key":"10.1016\/j.addr.2018.04.003_bb0080","first-page":"77","article-title":"The use of bronchial provocation tests for identifying asthma. A review of the problems for occupational assessment and a proposal for a new direction","volume":"3","author":"Freed","year":"2002","journal-title":"ADF Health"},{"key":"10.1016\/j.addr.2018.04.003_bb0085","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1183\/09031936.93.02010044","article-title":"Airway responses to hypertonic saline, exercise and histamine challenges in bronchial asthma","volume":"2","author":"Belcher","year":"1989","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.addr.2018.04.003_bb0090","first-page":"355","article-title":"Bronchial inhalation challenge with ultrasonically nebulized saline; comparison to exercise-induced asthma","volume":"57","author":"Kivity","year":"1986","journal-title":"Ann. Allergy"},{"key":"10.1016\/j.addr.2018.04.003_bb0095","first-page":"93","article-title":"Comparative effects of hyperosmolar saline inhalation and exercise in asthma","volume":"11","author":"Boulet","year":"1989","journal-title":"Immunol. Allergy Practice"},{"key":"10.1016\/j.addr.2018.04.003_bb0100","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1183\/09031936.97.10112465","article-title":"The effect of inhaling a dry powder of sodium chloride on the airways of asthmatic subjects","volume":"10","author":"Anderson","year":"1997","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.addr.2018.04.003_bb0105","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1164\/ajrccm.150.6.7952626","article-title":"Hypertonic saline challenge in an epidemiological survey of asthma in children","volume":"150","author":"Riedler","year":"1994","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.addr.2018.04.003_bb0110","first-page":"86","article-title":"Interaction between hyperosmolar and IgE-mediated histamine release from basophils and mast cells","volume":"130","author":"Eggleston","year":"1984","journal-title":"Am. Rev. Respir. Dis."},{"key":"10.1016\/j.addr.2018.04.003_bb0115","first-page":"1043","article-title":"A comparison of the osmotic activation of basophils and human lung mast cells","volume":"135","author":"Eggleston","year":"1987","journal-title":"Am. Rev. Respir. Dis."},{"key":"10.1016\/j.addr.2018.04.003_bb0120","series-title":"Thorax","article-title":"The hyperosmolar release of histamine from bronchoalveolar mast cells and its inhibition by sodium cromoglycate","volume":"40","author":"Flint","year":"1985"},{"key":"10.1016\/j.addr.2018.04.003_bb0125","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1164\/ajrccm\/137.3.606","article-title":"In vivo release of inflammatory mediators by hyperosmolar solutions","volume":"137","author":"Silber","year":"1988","journal-title":"Am. Rev. Respir. Dis."},{"key":"10.1016\/j.addr.2018.04.003_bb0130","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1136\/bmj.283.6302.1285","article-title":"Bronchial hyperreactivity in response to inhalation of ultrasonically nebulised solutions of distilled water and saline","volume":"283","author":"Schoeffel","year":"1981","journal-title":"Br. Med. J."},{"key":"10.1016\/j.addr.2018.04.003_bb0135","first-page":"211","article-title":"Alteration in osmolarity of inhaled aerosols cause bronchoconstriction and cough, but absence of a permeant anion causes cough alone","volume":"129","author":"Eschenbacher","year":"1984","journal-title":"Am. Rev. Respir. Dis."},{"key":"10.1016\/j.addr.2018.04.003_bb0140","first-page":"167","article-title":"The balance between biochemical and physical stability for inhalation protein powders: rhDNase as an example","volume":"1","author":"Clark","year":"1996","journal-title":"Respiratory Drug Delivery V."},{"key":"10.1016\/j.addr.2018.04.003_bb0145","doi-asserted-by":"crossref","first-page":"895","DOI":"10.3109\/03639049809097269","article-title":"Physicochemical stability of crystalline sugars and their spray-dried forms: dependence upon relative humidity and suitability for use in powder inhalers","volume":"24","author":"Venkatesh","year":"1998","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.addr.2018.04.003_bb0150","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1023\/A:1018929224005","article-title":"Feasibility study on spray-drying protein pharmaceuticals: recombinant human growth hormone and tissue-type plasminogen activator","volume":"11","author":"Mumenthaler","year":"1994","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2018.04.003_bb0155","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0168-3659(94)90155-4","article-title":"Bioavailability of pulmonary delivered peptides and proteins: \u03b1-interferon, calcitonins and parathyroid hormones","volume":"28","author":"Patton","year":"1994","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2018.04.003_bb0160","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1021\/js9504292","article-title":"Solid state characterization of spray-dried powders of recombinant human deoxyribonuclease (RhDNase)","volume":"87","author":"Chan","year":"1998","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.addr.2018.04.003_bb0165","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1023\/A:1012035113276","article-title":"Spray dried powders and powder blends of recombinant human deoxyribonuclease (rhDNase) for aerosol delivery","volume":"14","author":"Chan","year":"1997","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2018.04.003_bb0170","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1513\/pats.200409-049TA","article-title":"The lungs as a portal of entry for systemic drug delivery","volume":"1","author":"Patton","year":"2004","journal-title":"Proc. Am. Thorac. Soc."},{"key":"10.1016\/j.addr.2018.04.003_bb0175","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1021\/js970224o","article-title":"Determination of the glass properties of d-mannitol using sorbitol as an impurity","volume":"87","author":"Yu","year":"1998","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.addr.2018.04.003_bb0180","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1023\/A:1018952203687","article-title":"Influence of particle size, air flow, and inhaler device on the dispersion of mannitol powders as aerosols","volume":"16","author":"Chew","year":"1999","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2018.04.003_bb0185","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1164\/ajrccm.156.3.9701113","article-title":"A new method for bronchial-provocation testing in asthmatic subjects using a dry powder of mannitol","volume":"156","author":"Anderson","year":"1997","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.addr.2018.04.003_bb0190","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1164\/ajrccm.163.6.2006019","article-title":"Fexofenadine decreases sensitivity to and montelukast improves recovery from inhaled mannitol","volume":"163","author":"Brannan","year":"2001","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.addr.2018.04.003_bb0195","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1164\/ajrccm.158.4.9802087","article-title":"Responsiveness to mannitol in asthmatic subjects with exercise- and hyperventilation-induced asthma","volume":"158","author":"Brannan","year":"1998","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.addr.2018.04.003_bb0200","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1152\/japplphysiol.00108.2008","article-title":"Pulmonary gas exchange response to exercise- and mannitol- induced bronchoconstriction in mild asthma","volume":"105","author":"Munoz","year":"2008","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.addr.2018.04.003_bb0205","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1183\/09031936.06.00078205","article-title":"Inhibition of mast cell PGD2 release protects against mannitol-induced airway narrowing","volume":"27","author":"Brannan","year":"2006","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.addr.2018.04.003_bb0210","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1164\/ajrccm.161.6.9908096","article-title":"Nedocromil sodium inhibits responsiveness to inhaled mannitol in asthmatic subjects","volume":"161","author":"Brannan","year":"2000","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.addr.2018.04.003_bb0215","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1046\/j.1440-1843.2002.00357.x","article-title":"Budesonide reduces sensitivity and reactivity to inhaled mannitol in asthmatic subjects","volume":"7","author":"Brannan","year":"2002","journal-title":"Respirology"},{"key":"10.1016\/j.addr.2018.04.003_bb0220","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1378\/chest.124.4.1341","article-title":"Sensitivity and validity of three bronchial provocation tests to demonstrate the effect of inhaled corticosteroids in asthma","volume":"124","author":"Koskela","year":"2003","journal-title":"Chest"},{"key":"10.1016\/j.addr.2018.04.003_bb0225","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1164\/ajrccm.163.2.9912091","article-title":"Predictive markers of asthma exacerbations during stepwise dose-reduction of inhaled corticosteroids","volume":"163","author":"Leuppi","year":"2001","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.addr.2018.04.003_bb0230","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1183\/09031936.01.00058601","article-title":"Markers of airway inflammation and airway hyperresponsiveness in patients with well-controlled asthma","volume":"18","author":"Leuppi","year":"2001","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.addr.2018.04.003_bb0235","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1378\/chest.109.6.1520","article-title":"Eucapnic voluntary hyperventilation as a bronchoprovocation technique. Development of a standardized dosing schedule in asthmatics","volume":"109","author":"Argyros","year":"1996","journal-title":"Chest"},{"key":"10.1016\/j.addr.2018.04.003_bb0240","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1378\/chest.108.5.1240","article-title":"Interpretation of eucapnic voluntary hyperventilation in the diagnosis of asthma","volume":"108","author":"Hurwitz","year":"1995","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.addr.2018.04.003_bb0245","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/1465-9921-6-144","article-title":"The safety and efficacy of inhaled dry powder mannitol as a bronchial provocation test for airway hyperresponsiveness: a phase 3 comparison study with hypertonic (4.5%) saline","volume":"Dec 9","author":"Brannan","year":"2005","journal-title":"Respir. Res."},{"key":"10.1016\/j.addr.2018.04.003_bb0250","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1164\/rccm.200208-916OC","article-title":"Mannitol as a challenge test to identify exercise-induced bronchoconstriction in elite athletes","volume":"167","author":"Holzer","year":"2003","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.addr.2018.04.003_bb0255","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1378\/chest.124.6.2171","article-title":"Responsiveness to three bronchial provocation tests in patients with asthma","volume":"124","author":"Koskela","year":"2003","journal-title":"Chest"},{"key":"10.1016\/j.addr.2018.04.003_bb0260","series-title":"Monitoring Asthma","first-page":"275","article-title":"Monitoring airway hyper-responsiveness: Indirect stimuli-Exercise, hypertonic saline mannitol and adenosine monophosphate","author":"Anderson","year":"2005"},{"key":"10.1016\/j.addr.2018.04.003_bb0265","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.jaci.2012.08.028","article-title":"Mannitol (AridolTM) test results in asthmatic adults receiving inhaled corticosteroids","volume":"131","author":"Brannan","year":"2013","journal-title":"J. Allergy Clin. Immunol."},{"issue":"10","key":"10.1016\/j.addr.2018.04.003_bb0270","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1465-9921-10-4","article-title":"Comparison of mannitol and methacholine to predict exercise-induced bronchoconstriction and a clinical diagnosis of asthma","volume":"Jan 23","author":"Anderson","year":"2009","journal-title":"Respir. Res."},{"key":"10.1016\/j.addr.2018.04.003_bb0275","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1002\/ppul.21034","article-title":"Mannitol and exercise challenge tests in asthmatic children","volume":"44","author":"Kersten","year":"2009","journal-title":"Pediatr. Pulmonol."},{"key":"10.1016\/j.addr.2018.04.003_bb0280","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1002\/ppul.21453","article-title":"Mannitol dry powder challenge in comparison with exercise-testing in children","volume":"46","author":"Barben","year":"2011","journal-title":"Pediatr. Pulmonol."},{"key":"10.1016\/j.addr.2018.04.003_bb0285","doi-asserted-by":"crossref","DOI":"10.1186\/1465-9921-11-120","article-title":"Reproducibility of the airway response to an exercise protocol standardized for intensity, duration, and inspired air conditions, in subjects with symptoms suggestive of asthma","volume":"11","author":"Anderson","year":"2010","journal-title":"Respir. Res."},{"key":"10.1016\/j.addr.2018.04.003_bb0290","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1002\/ppul.10378","article-title":"Repeatability of bronchial responsiveness to mannitol dry powder in children with asthma","volume":"36","author":"Barben","year":"2003","journal-title":"Pediatr. Pulmonol."},{"key":"10.1016\/j.addr.2018.04.003_bb0295","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s00408-012-9396-6","article-title":"Relationship of mannitol challenge to methacholine challenge and inflammatory markers in persistent asthmatics receiving inhaled corticosteroids","volume":"190","author":"Anderson","year":"2012","journal-title":"Lung"},{"key":"10.1016\/j.addr.2018.04.003_bb0300","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1080\/02770900903015654","article-title":"Inflammatory subtypes in asthma are related to airway hyperresponsiveness to mannitol and exhaled NO","volume":"46","author":"Porsbjerg","year":"2009","journal-title":"J. Asthma"},{"key":"10.1016\/j.addr.2018.04.003_bb0305","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1365-2222.2007.02878.x","article-title":"Relationship between airway responsiveness to mannitol and to methacholine and markers of airway inflammation, peak flow variability and quality of life in asthma patients","volume":"38","author":"Porsbjerg","year":"2008","journal-title":"Clin. Exp. Allergy"},{"key":"10.1016\/j.addr.2018.04.003_bb0310","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1378\/chest.11-1748","article-title":"A randomized primary care trial of steroid titration against mannitol in persistent asthma: STAMINA trial","volume":"141","author":"Lipworth","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.addr.2018.04.003_bb0315","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.anai.2010.09.021","article-title":"Pathogenesis, prevalence, diagnosis, and management of exercise-induced bronchoconstriction: a practice parameter","volume":"105","author":"Weiler","year":"2010","journal-title":"Ann. Allergy Asthma Clin. Immunol."},{"key":"10.1016\/j.addr.2018.04.003_bb0320","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1164\/rccm.201303-0437ST","article-title":"An official ATS clinical practice guideline: exercise-induced bronchoconstriction","volume":"187","author":"Parsons","year":"2013","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.addr.2018.04.003_bb0325","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1152\/jappl.1977.43.1.46","article-title":"Effects of exercise and eucapnic hyperventilation on bronchial clearance in man","volume":"43","author":"Wolff","year":"1977","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.addr.2018.04.003_bb0330","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1152\/jappl.1990.69.1.362","article-title":"Mathematical modelling of the heat and water transport in the human respiratory tract","volume":"69","author":"Daviskas","year":"1990","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.addr.2018.04.003_bb0335","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0034-5687(91)90023-C","article-title":"Local airway heat and water vapour losses","volume":"84","author":"Daviskas","year":"1991","journal-title":"Respir. Physiol."},{"key":"10.1016\/j.addr.2018.04.003_bb0340","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1183\/09031936.95.08050742","article-title":"Changes in mucociliary clearance during and after isocapnic hyperventilation in asthmatic and healthy subjects","volume":"8","author":"Daviskas","year":"1995","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.addr.2018.04.003_bb0345","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1183\/09031936.96.09040725","article-title":"Inhalation of hypertonic saline aerosol enhances mucociliary clearance in asthmatic and healthy subjects","volume":"9","author":"Daviskas","year":"1996","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.addr.2018.04.003_bb0350","first-page":"199","article-title":"Enhanced clearance of secretions from the human lung after the administration of hypertonic saline aerosol","volume":"117","author":"Pavia","year":"1978","journal-title":"Am. Rev. Respir. Dis."},{"key":"10.1016\/j.addr.2018.04.003_bb0355","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1164\/ajrccm.153.5.8630593","article-title":"Effect of hypertonic saline, amiloride & cough on mucociliary clearance in patients with cystic fibrosis","volume":"153","author":"Robinson","year":"1996","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.addr.2018.04.003_bb0360","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1183\/09031936.97.10112449","article-title":"Inhalation of dry powder mannitol increases mucociliary clearance","volume":"10","author":"Daviskas","year":"1997","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.addr.2018.04.003_bb0365","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1034\/j.1399-3003.1999.14c30.x","article-title":"The effect of inhaled mannitol on bronchial mucus clearance in cystic fibrosis patients: a pilot study","volume":"14","author":"Robinson","year":"1999","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.addr.2018.04.003_bb0370","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1183\/09031936.00119707","article-title":"Effect of increasing doses of mannitol on mucus clearance in patients with bronchiectasis","volume":"31","author":"Daviskas","year":"2008","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.addr.2018.04.003_bb0375","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.rmed.2009.10.021","article-title":"Effect of mannitol and repetitive coughing on the sputum properties in bronchiectasis","volume":"104","author":"Daviskas","year":"2010","journal-title":"Respir. Med."},{"key":"10.1016\/j.addr.2018.04.003_bb0380","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1164\/ajrccm.159.6.9809074","article-title":"Inhalation of dry powder mannitol improves clearance of mucus in patients with bronchiectasis","volume":"159","author":"Daviskas","year":"1999","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.addr.2018.04.003_bb0385","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1378\/chest.119.2.414","article-title":"The 24hr effect of mannitol on the clearance of mucus in patients with bronchiectasis","volume":"119","author":"Daviskas","year":"2001","journal-title":"Chest"},{"key":"10.1016\/j.addr.2018.04.003_bb0390","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1016\/j.rmed.2010.05.019","article-title":"Beneficial effect of inhaled mannitol and cough in asthmatics with mucociliary dysfunction","volume":"104","author":"Daviskas","year":"2010","journal-title":"Respir. Med."},{"key":"10.1016\/j.addr.2018.04.003_bb0395","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1089\/jam.2006.19.522","article-title":"Lung deposition of mannitol powder aerosol in healthy subjects","volume":"19","author":"Glover","year":"2006","journal-title":"J. Aerosol Med."},{"key":"10.1016\/j.addr.2018.04.003_bb0400","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1586\/ers.12.72","article-title":"Effect of inhaled dry powder mannitol on mucus and its clearance","volume":"7","author":"Daviskas","year":"2013","journal-title":"Expert Rev. Respir. Med."},{"key":"10.1016\/j.addr.2018.04.003_bb0405","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1378\/chest.07-2294","article-title":"Inhaled mannitol improves lung function in cystic fibrosis","volume":"133","author":"Jaques","year":"2008","journal-title":"Chest"},{"key":"10.1016\/j.addr.2018.04.003_bb0410","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1378\/chest.09-2017","article-title":"Inhaled mannitol improves the hydration and surface properties of sputum in patients with cystic fibrosis","volume":"137","author":"Daviskas","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.addr.2018.04.003_bb0415","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1183\/09031936.00220513","article-title":"Quantitative imaging of airway liquid absorption in cystic fibrosis","volume":"44","author":"Locke","year":"2014","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.addr.2018.04.003_bb0420","first-page":"707","article-title":"A placebo controlled trial with inhaled mannitol improves health related quality of life in patients with bronchiectasis","volume":"24","author":"Daviskas","year":"2004","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.addr.2018.04.003_bb0425","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1440-1843.2005.00659.x","article-title":"Inhaled mannitol for the treatment of mucociliary dysfunction in patients with bronchiectasis: effect on lung function, health status and sputum","volume":"10","author":"Daviskas","year":"2005","journal-title":"Respirology"},{"key":"10.1016\/j.addr.2018.04.003_bb0430","series-title":"Thorax","first-page":"1073","article-title":"Inhaled mannitol for non-cystic fibrosis bronchiectasis: a randomised, controlled trial","volume":"69","author":"Bilton","year":"2014"},{"key":"10.1016\/j.addr.2018.04.003_bb0435","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1378\/chest.12-1763","article-title":"Phase 3 randomized study of the efficacy and safety of inhaled dry powder mannitol for the symptomatic treatment of non-cystic fibrosis bronchiectasis","volume":"144","author":"Bilton","year":"2013","journal-title":"Chest"},{"key":"10.1016\/j.addr.2018.04.003_bb0440","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1164\/rccm.201109-1666OC","article-title":"Long-term inhaled dry powder mannitol in cystic fibrosis: an international randomized study","volume":"185","author":"Aitken","year":"2012","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.addr.2018.04.003_bb0445","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1183\/09031936.00187510","article-title":"Inhaled dry powder mannitol in cystic fibrosis: an efficacy and safety study","author":"Bilton","year":"2011","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.addr.2018.04.003_bb0450","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.jcf.2017.02.003","article-title":"Inhaled dry powder mannitol in children with cystic fibrosis: a randomised efficacy and safety trial","volume":"16","author":"De Boeck","year":"2017","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.addr.2018.04.003_bb0455","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/nature10069","article-title":"Metabolite-enabled eradication of bacterial persisters by aminoglycosides","volume":"472","author":"Allison","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.addr.2018.04.003_bb0460","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0084220","article-title":"Mannitol enhances antibiotic sensitivity of persister bacteria in Pseudomonas aeruginosa biofilms","volume":"8","author":"Barraud","year":"2013","journal-title":"PLoS One"}],"container-title":["Advanced Drug Delivery Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X18300553?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X18300553?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,5]],"date-time":"2024-07-05T15:36:57Z","timestamp":1720193817000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169409X18300553"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":92,"alternative-id":["S0169409X18300553"],"URL":"https:\/\/doi.org\/10.1016\/j.addr.2018.04.003","relation":{},"ISSN":["0169-409X"],"issn-type":[{"value":"0169-409X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Repurposing excipients as active inhalation agents: The mannitol story","name":"articletitle","label":"Article Title"},{"value":"Advanced Drug Delivery Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.addr.2018.04.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}